Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Coot : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571

PHENIX : a comprehensive Python-based system for macromolecular structure solution

Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716

A novel coronavirus outbreak of global health concern

Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735

SARS and MERS: recent insights into emerging coronaviruses

de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

Zhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579

Targeting proteases: successes, failures and future prospects

Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Shin, D., Mukherjee, R., Grewe, D., Bojkova, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A. R., Tascher, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2601-5 · Cited by 1,177

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds

Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854

From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

Hilgenfeld, R. (2014) · The FEBS Journal · doi:10.1111/febs.12936 · Cited by 660

Emerging principles in protease-based drug discovery

Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601

The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity

Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Ratia, K., Pegan, S., Takayama, J., Sleeman, K., Coughlin, M., Baliji, S., Chaudhuri, R., Fu, W., Prabhakar, B. S., Johnson, M. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805240105 · Cited by 507

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2

Klemm, T., Ebert, G., Calleja, D. J., Allison, C. C., Richardson, L. W., Bernardini, J. P., Lu, B. G., Kuchel, N. W., Grohmann, C., Shibata, Y., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020106275 · Cited by 485

Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity

Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13600-13612.2004 · Cited by 462

Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus

Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411

The Papain-Like Protease from the Severe Acute Respiratory Syndrome Coronavirus Is a Deubiquitinating Enzyme

Lindner, H. A., Fotouhi-Ardakani, N., Lytvyn, V., Lachance, P., Sulea, T., & Ménard, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15199-15208.2005 · Cited by 371

Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 368

On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases

Ekkebus, R., van Kasteren, S. I., Kulathu, Y., Scholten, A., Berlin, I., Geurink, P. P., de Jong, A., Goerdayal, S., Neefjes, J., Heck, A. J. R., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309802n · Cited by 347

Chemical Synthesis of Ubiquitin, Ubiquitin‐Based Probes, and Diubiquitin

El Oualid, F., Merkx, R., Ekkebus, R., Hameed, D. S., Smit, J. J., de Jong, A., Hilkmann, H., Sixma, T. K., & Ovaa, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005995 · Cited by 318

Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases

Clementz, M. A., Chen, Z., Banach, B. S., Wang, Y., Sun, L., Ratia, K., Baez-Santos, Y. M., Wang, J., Takayama, J., Ghosh, A. K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02406-09 · Cited by 308

Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease

Freitas, B. T., Durie, I. A., Murray, J., Longo, J. E., Miller, H. C., Crich, D., Hogan, R. J., Tripp, R. A., & Pegan, S. D. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00168 · Cited by 290

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes

Lin, M.-H., Moses, D. C., Hsieh, C.-H., Cheng, S.-C., Chen, Y.-H., Sun, C.-Y., & Chou, C.-Y. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.015 · Cited by 250

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Mielech, A. M., Kilianski, A., Baez-Santos, Y. M., Mesecar, A. D., & Baker, S. C. (2014) · Virology · doi:10.1016/j.virol.2013.11.040 · Cited by 231

Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease

Ratia, K., Kilianski, A., Baez-Santos, Y. M., Baker, S. C., & Mesecar, A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004113 · Cited by 224

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease

Lindner, H. A., Lytvyn, V., Qi, H., Lachance, P., Ziomek, E., & Ménard, R. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.07.006 · Cited by 158

Expedient Solid-Phase Synthesis of Fluorogenic Protease Substrates Using the 7-Amino-4-carbamoylmethylcoumarin (ACC) Fluorophore

Maly, D. J., Leonetti, F., Backes, B. J., Dauber, D. S., Harris, J. L., Craik, C. S., & Ellman, J. A. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo016140o · Cited by 137

Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease

Békés, M., van Noort, G. J. V. D. H., Ekkebus, R., Ovaa, H., Huang, T. T., & Lima, C. D. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.016 · Cited by 137

Structural basis of the specificity of USP18 toward ISG15

Basters, A., Geurink, P. P., Röcker, A., Witting, K. F., Tadayon, R., Hess, S., Semrau, M. S., Storici, P., Ovaa, H., Knobeloch, K., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3371 · Cited by 135

Non-hydrolyzable Diubiquitin Probes Reveal Linkage-Specific Reactivity of Deubiquitylating Enzymes Mediated by S2 Pockets

Flierman, D., van Noort, G. J. V. D. H., Ekkebus, R., Geurink, P. P., Mevissen, T. E. T., Hospenthal, M. K., Komander, D., & Ovaa, H. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.03.009 · Cited by 107

Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity

Poręba, M., Salvesen, G. S., & Drąg, M. (2017) · Nature Protocols · doi:10.1038/nprot.2017.091 · Cited by 100

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes

Hewings, D. S., Heideker, J., Ma, T. P., AhYoung, A. P., Oualid, F. E., Amore, A., Costakes, G. T., Kirchhofer, D., Brasher, B. B., Pillow, T. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03511-6 · Cited by 93

A Native Chemical Ligation Handle that Enables the Synthesis of Advanced Activity-Based Probes: Diubiquitin as a Case Study

Mulder, M. P., Oualid, F. E., ter Beek, J., & Ovaa, H. (2014) · ChemBioChem · doi:10.1002/cbic.201402012 · Cited by 92

The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection

Calistri, A., Munegato, D., Carli, I., Parolin, C., & Palù, G. (2014) · Cells · doi:10.3390/cells3020386 · Cited by 86

Ubiquitin-Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes

de Jong, A., Merkx, R., Berlin, I., Rodenko, B., Wijdeven, R., el Atmioui, D., Yalçin, Z., Robson, C., Neefjes, J., & Ovaa, H. (2012) · ChemBioChem · doi:10.1002/cbic.201200497 · Cited by 77

Emerging challenges in the design of selective substrates, inhibitors and activity‐based probes for indistinguishable proteases

Kasperkiewicz, P., Poręba, M., Groborz, K. M., & Drąg, M. (2017) · FEBS Journal · doi:10.1111/febs.14001 · Cited by 71

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme

Békés, M., Rut, W., Kasperkiewicz, P., Mulder, M. P. C., Ovaa, H., Drąg, M., Lima, C. D., & Huang, T. T. (2015) · Biochemical Journal · doi:10.1042/bj20141170 · Cited by 69

Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes)

Drąg, M., Mikolajczyk, J., Békés, M., Reyes‐Turcu, F. E., Ellman, J. A., Wilkinson, K. D., & Salvesen, G. S. (2008) · Biochemical Journal · doi:10.1042/bj20080779 · Cited by 61

Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugsPreprint

Anson, B. J., Chapman, M. E., Lendy, E. K., et al. (2020) · doi:10.21203/rs.3.rs-26344/v1 · Cited by 42

Deubiquitinating Activity of the SARS-CoV Papain-Like Protease

Barretto, N., Jukneliene, D., Ratia, K. M., et al. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-33012-9_5 · Cited by 37

Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples

Rut, W., Poręba, M., Kasperkiewicz, P., Snipas, S. J., & Drąg, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00026 · Cited by 33

Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses

Rut, W., Groborz, K. M., Zhang, L., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104731 · Cited by 27

Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes

Rut, W., Żmudziński, M., Snipas, S. J., Békés, M., Huang, T. T., & Drąg, M. (2020) · Chemical Science · doi:10.1039/d0sc01347a · Cited by 25

Structural insights into SARS-CoV-2 proteins

Arya, R., Kumari, S., Pandey, B., Mistry, H., Bihani, S. C., Das, A., Prashar, V., Gupta, G. D., Panicker, L., & Kumar, M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.11.024 · Cited by 348

Crystal structure of SARS-CoV-2 papain-like protease

Gao, X., Qin, B., Chen, P., Zhu, K., Hou, P., Wojdyla, J. A., Wang, M., & Cui, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.014 · Cited by 336

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery

Fu, Z., Huang, B., Tang, J., Liu, S., Liu, M., Ye, Y., Liu, Z., Xiong, Y., Zhu, W., Cao, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20718-8 · Cited by 322

Structural biology of SARS-CoV-2: open the door for novel therapies

Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 291

SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19

Perez-Bermejo, J. A., Kang, S., Rockwood, S. J., Simoneau, C. R., Joy, D. A., Silva, A. C., Ramadoss, G. N., Flanigan, W. R., Fozouni, P., Li, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7872 · Cited by 259